|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-1
|
|
pubmed:abstractText |
The American Thoracic Society/European Respiratory Society jointly created a Task Force on "Outcomes for COPD pharmacological trials: from lung function to biomarkers" to inform the chronic obstructive pulmonary disease research community about the possible use and limitations of current outcomes and markers when evaluating the impact of a pharmacological therapy. Based on their review of the published literature, the following document has been prepared with individual sections that address specific outcomes and markers, and a final section that summarises their recommendations.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1399-3003
|
|
pubmed:author |
pubmed-author:American Thoracic Society,
pubmed-author:BarneyP LPL,
pubmed-author:BrusascoVV,
pubmed-author:BurgeP SPS,
pubmed-author:CalverleyP M APM,
pubmed-author:CazzolaMM,
pubmed-author:CelliB RBR,
pubmed-author:European Respiratory Society Task Force on outcomes of COPD,
pubmed-author:FranciosiL GLG,
pubmed-author:JonesP WPW,
pubmed-author:MacNeeWW,
pubmed-author:MahlerD ADA,
pubmed-author:MakaFF,
pubmed-author:MartinezF JFJ,
pubmed-author:MiravitllesMM,
pubmed-author:PageC PCP,
pubmed-author:PalangePP,
pubmed-author:ParrDD,
pubmed-author:PistolesiMM,
pubmed-author:RabeK FKF,
pubmed-author:RennardS ISI,
pubmed-author:Rutten-van MölkenM PMP,
pubmed-author:StockleyRR,
pubmed-author:SullivanS DSD,
pubmed-author:WedzichaJ AJA,
pubmed-author:WoutersE FEF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
416-69
|
|
pubmed:dateRevised |
2008-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18238951-Adrenal Cortex Hormones,
pubmed-meshheading:18238951-Advisory Committees,
pubmed-meshheading:18238951-Biological Markers,
pubmed-meshheading:18238951-Bronchodilator Agents,
pubmed-meshheading:18238951-Clinical Trials as Topic,
pubmed-meshheading:18238951-Female,
pubmed-meshheading:18238951-Humans,
pubmed-meshheading:18238951-Male,
pubmed-meshheading:18238951-Practice Guidelines as Topic,
pubmed-meshheading:18238951-Prognosis,
pubmed-meshheading:18238951-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:18238951-Respiratory Function Tests,
pubmed-meshheading:18238951-Risk Assessment,
pubmed-meshheading:18238951-Societies, Medical,
pubmed-meshheading:18238951-Survival Analysis,
pubmed-meshheading:18238951-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
|
|
pubmed:affiliation |
Unit of Respiratory Diseases, Dept of Internal Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. mario.cazzola@uniroma2.it
|
|
pubmed:publicationType |
Journal Article,
Review
|
